372 related articles for article (PubMed ID: 29290821)
1. Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.
Yang C; Wu T; Qi Y; Zhang Z
Theranostics; 2018; 8(2):464-485. PubMed ID: 29290821
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.
Tan S; Zou C; Zhang W; Yin M; Gao X; Tang Q
Drug Deliv; 2017 Nov; 24(1):1831-1842. PubMed ID: 29182031
[TBL] [Abstract][Full Text] [Related]
3. The applications of Vitamin E TPGS in drug delivery.
Guo Y; Luo J; Tan S; Otieno BO; Zhang Z
Eur J Pharm Sci; 2013 May; 49(2):175-86. PubMed ID: 23485439
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers based on vitamin E-TPGS: Design principle and molecular insights into improving the efficacy of anticancer drugs.
Rathod S; Bahadur P; Tiwari S
Int J Pharm; 2021 Jan; 592():120045. PubMed ID: 33212172
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E TPGS as a molecular biomaterial for drug delivery.
Zhang Z; Tan S; Feng SS
Biomaterials; 2012 Jun; 33(19):4889-906. PubMed ID: 22498300
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E-based nanomedicines for anti-cancer drug delivery.
Duhem N; Danhier F; Préat V
J Control Release; 2014 May; 182():33-44. PubMed ID: 24631865
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
8. Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition.
Yang C; Qin Y; Tu K; Xu C; Li Z; Zhang Z
Colloids Surf B Biointerfaces; 2018 Sep; 169():10-19. PubMed ID: 29747026
[TBL] [Abstract][Full Text] [Related]
9. TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance.
Tian G; Zheng X; Zhang X; Yin W; Yu J; Wang D; Zhang Z; Yang X; Gu Z; Zhao Y
Biomaterials; 2015 Feb; 40():107-16. PubMed ID: 25433607
[TBL] [Abstract][Full Text] [Related]
10. Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
Qi Y; Qin X; Yang C; Wu T; Qiao Q; Song Q; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1005-1016. PubMed ID: 29397749
[TBL] [Abstract][Full Text] [Related]
11. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
[TBL] [Abstract][Full Text] [Related]
12. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment.
Guan Y; Wang LY; Wang B; Ding MH; Bao YL; Tan SW
Curr Med Sci; 2020 Apr; 40(2):218-231. PubMed ID: 32337683
[TBL] [Abstract][Full Text] [Related]
14. Redefine the role of d-α-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance.
Chen JY; Sung CJ; Chen SC; Hsiang YP; Hsu YC; Teng YN
Eur J Pharm Sci; 2023 Nov; 190():106579. PubMed ID: 37689120
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
[TBL] [Abstract][Full Text] [Related]
16. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
17. Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.
Vijayakumar MR; Muthu MS; Singh S
Expert Opin Drug Deliv; 2013 Apr; 10(4):529-43. PubMed ID: 23316695
[TBL] [Abstract][Full Text] [Related]
18. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
19. Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.
Muddineti OS; Ghosh B; Biswas S
Expert Opin Drug Deliv; 2017 Jun; 14(6):715-726. PubMed ID: 27560621
[TBL] [Abstract][Full Text] [Related]
20. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
